Evaluation of Image-Defined Risk Factor (IDRF) Assessment in Patients With Intermediate-risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531

jpedsurg.org

The International Neuroblastoma Risk Group (INRG) classifier utilizes a staging system based on pretreatment imaging criteria in which image-defined risk factors (IDRFs) are used to evaluate the extent of locoregional disease. Children's Oncology Group (COG) study ANBL0531 prospectively examined institutional determination of IDRF status and compared that to a standardized central review.

jpedsurg.org shows its articles on its own site.

Read the article on jpedsurg.org ↗

Article · Sep 2024 · 1 min read

In brief

This study evaluates how accurately institutions assess image-defined risk factors (IDRFs) in intermediate-risk neuroblastoma patients compared to standardized central review. The research examines the reliability of IDRF-based staging criteria used in the International Neuroblastoma Risk Group classification system through prospective analysis of COG study ANBL0531 data.

INRG staging uses image-defined risk factors (IDRFs) to assess locoregional neuroblastoma extent before treatment.
COG study ANBL0531 compared institutional IDRF assessments to standardized central review for quality assurance.
Prospective validation of IDRF criteria helps standardize risk stratification in intermediate-risk neuroblastoma patients.

Written by the GCMD Library team from the article.

Read it at the source ↗